Early test pits new obesity drug formulations Head-to-Head
NCT ID NCT07220954
Summary
This early-stage study aims to compare how different injected formulations of the experimental drug AZD6234 are absorbed into the bloodstream. It involves about 21 healthy volunteers who will each try four different versions of the injection. The main goal is to see which formulation gets into the blood best and to check for side effects, not to treat a medical condition.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY PARTICIPANTS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Site
Ruddington, NG11 6JS, United Kingdom
Conditions
Explore the condition pages connected to this study.